Skip to main content
Canada’s most-awarded newsroom for a reason
Enjoy unlimited digital access
$1.99
per week
for 24 weeks
Canada’s most-awarded newsroom for a reason
$1.99
per week
for 24 weeks
// //

Hls Therapeutics Inc TSX: HLS-T

Today's Change
Volume
Real-Time Last Update TSX Last Sale

More stories below advertisement

Latest Press Releases

Saladax Biomedical and HLS Therapeutics Strengthen Partnership With an Exclusive Distribution Agreement for Canada
Business Wire - Thu Nov 18, 2021
Business Wire - PRTGAM
Thu Nov 18, 2021
Saladax Biomedical, Inc (Saladax) is pleased to announce an exclusive distribution agreement with HLS Therapeutics Inc. (“HLS”) (TSX:HLS) to distribute five MyCare™ Psychiatry Laboratory Assays used to measure the six most commonly prescribed...
HLS Therapeutics to Host Q3 2021 Financial Results Conference Call
Canada Newswire - Thu Oct 21, 2021
Canada Newswire - PRTGAM
Thu Oct 21, 2021
TORONTO , Oct. 21, 2021 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q3 2021 financial results on Thursday, November 4, 2021 . The Company will hold a conference call that same day at 8:30 a.m. EDT to discuss its results. The call will be hosted by Mr. Gilbert Godin , Chief Executive Officer and Mr. Tim Hendrickson , Chief Financial Officer. Slides to accompany management's prepared remarks will be available to view via the webcast .
Life Sciences Company Investor Presentations Now Available for On-Demand Viewing
Globe NewsWire - Mon Dec 21, 2020
Globe NewsWire - PRTGAM
Mon Dec 21, 2020
Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentations
HLS Therapeutics to Webcast Live at Life Sciences Investor Forum December 17th
Globe NewsWire - Mon Dec 14, 2020
Globe NewsWire - PRTGAM
Mon Dec 14, 2020
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.com
Virtual Conference for Life Sciences Companies Broadcast Live December 17th, 2020
Globe NewsWire - Mon Dec 14, 2020
Globe NewsWire - PRTGAM
Mon Dec 14, 2020
Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com
HLS Therapeutics Announces Q2 2020 Financial Results
Canada Newswire - Thu Aug 6, 2020
Canada Newswire - PRTGAM
Thu Aug 6, 2020
Revenue of $12.6 million and Adjusted EBITDA of $4.8 million Increasing peak-year sales estimate for Vascepa to C$275 -325 million Clozaril's Canadian patient count and sales in local currency increase 2.3% and 2.5%, respectively, demonstrating resilience during the COVID-19 pandemic Privately covered lives for Vascepa in Canada increase to 40% as of today's date CEO succession: Gilbert Godin , President & COO, named CEO to replace Greg Gubitz who is retiring
HLS Therapeutics Reports Annual Meeting Results
Canada Newswire - Fri Jun 19, 2020
Canada Newswire - PRTGAM
Fri Jun 19, 2020
TORONTO , June 19, 2020 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a specialty pharmaceutical company focused on central nervous system and cardiovascular markets, announces voting results from its Annual Meeting of Shareholders held on June 19, 2020 in Toronto, Ontario .
HLS Therapeutics to Present at the Raymond James Human Health Innovation Conference
Canada Newswire - Wed Jun 17, 2020
Canada Newswire - PRTGAM
Wed Jun 17, 2020
TORONTO , June 17, 2020 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX:HLS), a specialty pharmaceutical company focused on central nervous system and cardiovascular markets, announces that Gilbert Godin , President and Chief Operating Officer, will present at the Raymond James Human Health Innovation Conference on Thursday June 18, 2020 at 11:40 a.m. Eastern Daylight Time . The conference will be held in a virtual meeting format.
HLS Therapeutics Confirms Annual Shareholders' Meeting
Canada Newswire - Wed Jun 10, 2020
Canada Newswire - PRTGAM
Wed Jun 10, 2020
TORONTO, ON , June 10, 2020 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a specialty pharmaceutical company focusing on central nervous system and cardiovascular markets, confirms that its Annual Meeting of Shareholders (the "Meeting") will take place at the offices of Blake, Cassels & Graydon LLP, 199 Bay Street, Commerce Court West, Suite 4000, Toronto, Ontario , on Friday June 19, 2020 at 10:00 a.m. ( Toronto time).
HLS Therapeutics to Present at the Jefferies Virtual Healthcare Conference
Canada Newswire - Mon Jun 1, 2020
Canada Newswire - PRTGAM
Mon Jun 1, 2020
TORONTO , June 1, 2020 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a specialty pharmaceutical company focused on central nervous system and cardiovascular markets, announces that Greg Gubitz , Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference on Wednesday June 3, 2020 at 9:00 a.m. Eastern Daylight Time .

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2022.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies